Cambridge biotech lays off 150 people as it winds down

Vor Bio to lay off 147 workers, wind down operations - The Boston Globe

The company, which was founded in 2015 to develop therapies for blood cancers, pointed to “currently available clinical data from its key clinical programs and a challenging fundraising environment.”

Cambridge biotech lays off 150 people as it winds down

A Cambridge biotech working to treat blood cancers is winding down operations and letting go of the majority of its team.

Blood cancer biotech Vor Bio ends clinical work, lays off 95% of staff

Vor Bio, founded by famed cancer biologist Siddhartha Mukherjee, is looking for a way out. Its decision to pursue strategic alternatives is similar to so many of its biotech peers, which have found themselves weathering a yearslong downturn.